Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 29 Nov 2000):

Multivariate analysis of long-term results after an axillobifemoral and aortobifemoral bypass in patients with aortoiliac occlusive disease.

Full Abstract

BACKGROUND: Controversy still remains regarding the long-term results and indications for axillofemoral bypass (AxFB). A comparison of axillobifemoral bypass (AxBFB) and aortobifemoral bypass (ABFB) was thus conducted to determine whether AxFB is an acceptable alternative vascular procedure to anatomic bypass for high-risk patients. METHODS: Sixty-three patients who underwent a total of 25 AxBFBs and 38 ABFBs for aortoiliac occlusive disease were reviewed retrospectively, and both univariate and multivarate analyses were perfomed. RESULTS: The overall survival was 82.8% at five years. A univariate analysis revealed significantly lower survival rates for patients with limb-threatening ischemia, coronary disease, and cerebrovascular disease. A multivariate analysis disclosed no significant factors influencing survival rates. The overall primary patency was 79.8% at five years. The primary patency rates for AxBFB (67.7% at five years) were significantly lower than for ABFB (88.5% at five years) based on a univariate analysis (p=0.0045). In addition, the secondary patency rates for AxBFB (80.3% at five years) were significantly lower than for ABFB (96.5% at five years, p=0.0025). A multivariate analysis disclosed significantly lower primary patency rates for grafts with a higher angiographic outflow score and simultaneous infrainguinal reconstructive procedures, but the differences between AxBFB and ABFB were not significant. CONCLUSIONS: The survival and primary patency for the AxBFB group were both inferior to the ABFB group, however a multivarate analysis disclosed no significant differences between the two groups. Poor femoral run-off and the presence of synchronous infrainguinal reconstructive procedures significantly affected graft patency, and these factors modulated the patency of AxBFB. AxFB for aortoiliac occlusive disease is therefore considered to be an acceptable procedure in appropriately selected patients.

 

Author information

Author/s: Onohara, T (T); Komori, K (K); Kume, M (M); Ishida, M (M); Ohta, S (S); Takeuchi, K (K); Matsumoto, T (T); Sugimachi, K (K);

Affiliation: Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Journal and publication information

Publication Type: Comparative Study; Journal Article

Journal: The Journal of cardiovascular surgery (J Cardiovasc Surg (Torino)), published in Italy. (Language: eng)

Reference: 2000-Dec; vol 41 (issue 6) : pp 905-10

Dates: Created 2001/03/05; Completed 2001/03/22; Revised 2009/11/11;

PMID: 11232974, status: MEDLINE (last retrieval date: 11/11/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Biocompatible Materials (0) ; Polyethylene Terephthalates (0) ; Polytetrafluoroethylene (9002-84-0)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

1/30/1974
2/28/1992
Higher Relevance Score (21)
Lower Relevance Score (18)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index